161 related articles for article (PubMed ID: 29497977)
1. Five-year postsurgical monitoring of serum p53 antibody for locally advanced esophageal squamous cell carcinoma.
Kochi R; Yajima S; Nanami T; Suzuki T; Oshima Y; Tokura N; Takatsuka J; Funahashi K; Tochigi N; Shimada H
Clin J Gastroenterol; 2018 Aug; 11(4):278-281. PubMed ID: 29497977
[TBL] [Abstract][Full Text] [Related]
2. Serum p53 antibody as a predictor of early recurrence in patients with postoperative esophageal squamous cell carcinoma.
Takahashi K; Miyashita M; Nomura T; Makino H; Futami R; Kashiwabara M; Katsuta M; Tajiri T
Dis Esophagus; 2007; 20(2):117-22. PubMed ID: 17439594
[TBL] [Abstract][Full Text] [Related]
3. Peritherapeutic Serum p53 Antibody Titers are Predictors of Survival in Patients with Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemotherapy and Surgery.
Yamashita K; Makino T; Tanaka K; Yamasaki M; Yamamoto M; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
World J Surg; 2017 Jun; 41(6):1566-1574. PubMed ID: 28108772
[TBL] [Abstract][Full Text] [Related]
4. Perioperative changes of serum p53 antibody titer is a predictor for survival in patients with esophageal squamous cell carcinoma.
Shimada H; Shiratori T; Takeda A; Matsushita K; Okazumi S; Akutsu Y; Matsubara H; Nomura F; Ochiai T
World J Surg; 2009 Feb; 33(2):272-7. PubMed ID: 19052812
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of preoperative serum p53 antibody titers in 1487 patients with surgically treated esophageal squamous cell carcinoma: a multi-institutional study.
Takashi S; Satoshi Y; Akihiko O; Naoya Y; Yusuke T; Kentaro M; Yu O; Yasuaki N; Koichi Y; Takashi F; Ryo O; Isamu H; Chikara K; Kosuke N; Yasuhiro T; Kazuhiko Y; Hideaki S
Esophagus; 2021 Jan; 18(1):65-71. PubMed ID: 32715348
[TBL] [Abstract][Full Text] [Related]
6. Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection.
Chen J; Wu S; Zheng X; Pan J; Zhu K; Chen Y; Li J; Liao L; Lin Y; Liao Z
BMC Surg; 2014 Dec; 14():110. PubMed ID: 25527100
[TBL] [Abstract][Full Text] [Related]
7. Detection of circulating anti-p53 antibodies in esophageal cancer patients.
Hagiwara N; Onda M; Miyashita M; Sasajima K
J Nippon Med Sch; 2000 Apr; 67(2):110-7. PubMed ID: 10754600
[TBL] [Abstract][Full Text] [Related]
8. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807
[TBL] [Abstract][Full Text] [Related]
9. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma.
Kunizaki M; Hamasaki K; Wakata K; Tobinaga S; Sumida Y; Hidaka S; Yasutake T; Miyazaki T; Matsumoto K; Yamasaki T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
Anticancer Res; 2018 Mar; 38(3):1807-1813. PubMed ID: 29491120
[TBL] [Abstract][Full Text] [Related]
10. Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma.
Shimada H; Takeda A; Arima M; Okazumi S; Matsubara H; Nabeya Y; Funami Y; Hayashi H; Gunji Y; Suzuki T; Kobayashi S; Ochiai T
Cancer; 2000 Oct; 89(8):1677-83. PubMed ID: 11042560
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of high serum p53 antibody titers in patients with esophageal squamous cell carcinoma.
Suzuki T; Yajima S; Ishioka N; Nanami T; Oshima Y; Washizawa N; Funahashi K; Otsuka S; Nemoto T; Shimada H
Esophagus; 2018 Oct; 15(4):294-300. PubMed ID: 29959634
[TBL] [Abstract][Full Text] [Related]
12. Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels.
Ma Q; Liu W; Jia R; Jiang F; Duan H; Lin P; Zhang L; Long H; Zhao H; Ma G
World J Surg Oncol; 2016 May; 14():141. PubMed ID: 27151090
[TBL] [Abstract][Full Text] [Related]
13. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Gunji Y; Kobayashi S; Hayashi H; Ochiai T
Surgery; 2003 May; 133(5):486-94. PubMed ID: 12773976
[TBL] [Abstract][Full Text] [Related]
14. Long-term monitoring of serum p53 antibody after neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: report of a case.
Shimada H; Nagata M; Cho A; Takiguchi N; Kainuma O; Soda H; Ikeda A; Nabeya Y; Yajima S; Yamamoto H; Sugiyama T; Itami M
Surg Today; 2014 Oct; 44(10):1957-61. PubMed ID: 24241479
[TBL] [Abstract][Full Text] [Related]
15. Preoperative Cyfra21-1 and SCC-Ag serum titers predict survival in patients with stage II esophageal squamous cell carcinoma.
Cao X; Zhang L; Feng GR; Yang J; Wang RY; Li J; Zheng XM; Han YJ
J Transl Med; 2012 Sep; 10():197. PubMed ID: 22999061
[TBL] [Abstract][Full Text] [Related]
16. Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Tagawa M; Okazumi S; Matsubara H; Kadomatsu K; Muramatsu T; Ikematsu S; Sakuma S; Ochiai T
Cancer Sci; 2003 Jul; 94(7):628-32. PubMed ID: 12841873
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of serum high-mobility group box 1 detection in esophageal squamous cell carcinoma].
Chen CG; Cui L; Tang P; Yu ZT
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):838-41. PubMed ID: 24061989
[TBL] [Abstract][Full Text] [Related]
18. Preoperative squamous cell carcinoma antigen and albumin serum levels predict the survival of patients with stage T1-3N0M0 esophageal squamous cell carcinoma: a retrospective observational study.
Wu LL; Liu X; Huang W; Lin P; Long H; Zhang LJ; Ma GW
J Cardiothorac Surg; 2020 May; 15(1):115. PubMed ID: 32456707
[TBL] [Abstract][Full Text] [Related]
19. Monitoring disease progression and treatment efficacy with circulating tumor cells in esophageal squamous cell carcinoma: A case report.
Qiao YY; Lin KX; Zhang Z; Zhang DJ; Shi CH; Xiong M; Qu XH; Zhao XH
World J Gastroenterol; 2015 Jul; 21(25):7921-8. PubMed ID: 26167094
[TBL] [Abstract][Full Text] [Related]
20. Optimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus.
Kanda M; Koike M; Shimizu D; Tanaka C; Kobayashi D; Hattori N; Hayashi M; Omae K; Yamada S; Nakayama G; Kodera Y
Ann Surg Oncol; 2020 Apr; 27(4):1233-1240. PubMed ID: 31650302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
